Patents Assigned to HepaVec AG fur Gentherapie
  • Human liver cell line
    Patent number: 6046050
    Abstract: The invention refers to a new human liver cell line which may be used for toxicological, physiological and, in particular, gene therapeutic examinations. Fields of application are molecular biology, medicine and pharmaceutical industry. The new human liver cell line is marked positive owing to the parameters albumin and alpha-1-antitrypsin (ATT) and negative owing to alpha-fetoprotein (AFP). It has been deposited in the Deutsche Sammlung von Mikroorganismen (DSM ACC2302).
    Type: Grant
    Filed: March 5, 1998
    Date of Patent: April 4, 2000
    Assignee: HepaVec AG fur Gentherapie
    Inventors: Michael Strauss, Ira Kirillowa